Quick answer: Semax and Selank are two small peptides developed at the same research institute in Russia, and both are actually approved medications there, something almost no other peptide discussed on this site can say. Semax is built to boost a brain growth factor called BDNF and is approved in Russia for stroke recovery and cognitive issues. Selank calms the GABA system and is approved there for anxiety. Neither is approved in the United States, where both are sold only as research peptides.
Where They Came From
Both peptides were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, starting in the 1980s and 1990s. Semax comes from a small piece of a natural hormone called ACTH, engineered to keep its effect on the brain while removing the part that affects your body's stress hormone response. Selank comes from a different natural peptide called tuftsin, which is tied to immune function, and was adapted specifically for its calming effect on the brain.
How Semax Is Thought to Work
Semax's main studied effect is raising levels of BDNF, a protein your brain uses to support the growth and survival of neurons. Animal research has also linked it to increased activity in dopamine and serotonin pathways, which lines up with its reputation as more of a mental energy and focus peptide. In Russia, Semax has clinical approval for use in stroke recovery and certain cognitive disorders, and it has been added to that country's list of essential medicines.
How Selank Is Thought to Work
Selank works through a different system, mainly the GABA pathway, your brain's primary calming signal. Unlike many anti-anxiety medications, which reduce anxiety at the cost of also dulling cognitive sharpness, Selank is studied specifically for combining anxiety reduction with maintained or even improved mental clarity. It also appears to affect serotonin and some markers tied to inflammation, which researchers think may link stress and anxiety at a biological level. Selank is approved in Russia for generalized anxiety disorder and a condition called neurasthenia, a form of chronic stress-related fatigue.
Why They Get Paired Together
Because Semax leans toward mental energy and drive while Selank leans toward calm and reduced anxiety, the two are frequently discussed together as a way to get focus without the jittery, overstimulated feeling that Semax alone can sometimes produce. This pairing did not come from a specific combination clinical trial. It comes from the two peptides' individually studied, and seemingly complementary, mechanisms.
Why Neither Is Approved Outside Russia
Almost all of the clinical research behind both peptides comes from Russian research groups and Russian medical journals. That research includes real, published clinical approval in Russia, which is genuinely more human clinical history than most other research peptides discussed on this site have. But it has not gone through the FDA's approval process, and independent replication of the Russian findings by researchers outside that country remains limited. This is why, in the United States and most other countries, both Semax and Selank are sold strictly as research use only peptides.
Myth vs. Fact
Myth: Since Semax and Selank are approved medications somewhere, they are just as well established as any other approved drug. Fact: Their approval is specific to Russia, based largely on Russian clinical research that has not been independently replicated as widely as an FDA approved drug's evidence base typically is.
Myth: Semax and Selank work the same way, just with different names. Fact: They work through different systems entirely, BDNF and dopamine pathways for Semax, GABA and serotonin pathways for Selank, which is exactly why people discuss combining them rather than choosing one over the other.
Bottom Line
Semax and Selank have an unusual position in this space. They carry real clinical approval and use in Russia, more human history than most peptides covered here, but that approval has not extended to the United States, where both remain in research use only territory with limited independent Western research to back up the Russian findings.
Research use only outside of Russia, where regulatory status differs. This article is for general education and is not medical advice. Talk to a licensed doctor before making any health decision.
Sources referenced: Institute of Molecular Genetics, Russian Academy of Sciences research on Semax and Selank development; Russian clinical approval records summarized by Peptidepedia and peptides.fyi; independent mechanism research on BDNF and GABA pathways.
